Smith & Nephew Forecasted Growth

Future criteria checks 4/6

Smith & Nephew is forecasted to grow earnings and revenue by 26.4% and 5.1% per annum respectively. EPS is expected to grow by 26.2%. Return on equity is forecast to be 15.1% in 3 years.

Key information

26.4%

Earnings growth rate

26.2%

EPS growth rate

Medical Equipment earnings growth	27.8%
Revenue growth rate	5.1%
Future return on equity	15.1%
Analyst coverage	Good
Last updated	18 Sep 2023

Recent future growth updates

Recent updates

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 65% Above Its Share Price

Sep 11

Smith & Nephew (LON:SN.) Has A Pretty Healthy Balance Sheet

Aug 19

Investors Could Be Concerned With Smith & Nephew's (LON:SN.) Returns On Capital

Jul 17

Smith & Nephew plc (LON:SN.) Shares Could Be 22% Below Their Intrinsic Value Estimate

Jun 11

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 99% Above Its Share Price

Oct 26

These 4 Measures Indicate That Smith & Nephew (LON:SN.) Is Using Debt Reasonably Well

Aug 11

There Are Reasons To Feel Uneasy About Smith & Nephew's (LON:SN.) Returns On Capital

Jul 28

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 58% Above Its Share Price

Jun 26

Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital

Apr 29

These 4 Measures Indicate That Smith & Nephew (LON:SN.) Is Using Debt Safely

Mar 26

Earnings Beat: Smith & Nephew plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 24

Smith & Nephew's (LON:SN.) Returns On Capital Not Reflecting Well On The Business

Jan 25

Are Investors Undervaluing Smith & Nephew plc (LON:SN.) By 30%?

Dec 02

Smith & Nephew (LON:SN.) Might Be Having Difficulty Using Its Capital Effectively

Oct 23

Smith & Nephew (LON:SN.) Could Easily Take On More Debt

Oct 09

A Look At The Intrinsic Value Of Smith & Nephew plc (LON:SN.)

Aug 22

Be Wary Of Smith & Nephew (LON:SN.) And Its Returns On Capital

Jun 09

Smith & Nephew (LON:SN.) Has A Pretty Healthy Balance Sheet

May 25

A Look At The Intrinsic Value Of Smith & Nephew plc (LON:SN.)

May 10

Earnings and Revenue Growth Forecasts

LSE:SN. - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	6,109	738	865	1,322	12
12/31/2024	5,829	607	674	1,197	15
12/31/2023	5,546	433	456	964	14
7/1/2023	5,349	218	22	374	N/A
4/1/2023	5,282	221	66	421	N/A
12/31/2022	5,215	223	110	468	N/A
9/30/2022	5,214	360	213	595	N/A
7/2/2022	5,213	496	315	721	N/A
4/2/2022	5,213	510	392	799	N/A
12/31/2021	5,212	524	469	877	N/A
9/30/2021	5,168	539	632	1,051	N/A
7/3/2021	5,124	553	795	1,225	N/A
4/3/2021	4,842	501	644	1,080	N/A
12/31/2020	4,560	448	492	935	N/A
9/30/2020	4,624	420	420	863	N/A
6/27/2020	4,688	391	347	790	N/A
3/27/2020	4,913	496	554	979	N/A
12/31/2019	5,138	600	760	1,168	N/A
9/30/2019	5,044	649	762	1,127	N/A
6/29/2019	4,949	698	763	1,085	N/A
3/29/2019	4,927	681	674	1,008	N/A
12/31/2018	4,904	663	584	931	N/A
9/30/2018	4,887	690	622	984	N/A
6/30/2018	4,869	717	660	1,036	N/A
3/31/2018	4,817	742	687	1,063	N/A
12/31/2017	4,765	767	714	1,090	N/A
9/30/2017	4,721	817	625	1,011	N/A
7/1/2017	4,677	867	535	931	N/A
4/1/2017	4,673	826	N/A	890	N/A
12/31/2016	4,669	784	N/A	849	N/A
9/30/2016	4,680	570	N/A	829	N/A
7/2/2016	4,690	356	N/A	809	N/A
4/2/2016	4,662	383	N/A	920	N/A
12/31/2015	4,634	410	N/A	1,030	N/A
9/30/2015	4,702	513	N/A	1,062	N/A
6/27/2015	4,669	557	N/A	940	N/A
3/27/2015	4,680	499	N/A	837	N/A
12/31/2014	4,617	501	N/A	683	N/A
9/27/2014	4,543	503	N/A	702	N/A
6/28/2014	4,422	523	N/A	753	N/A
3/29/2014	4,349	563	N/A	766	N/A
12/31/2013	4,351	556	N/A	867	N/A
9/28/2013	4,253	534	N/A	798	N/A
6/29/2013	4,178	544	N/A	851	N/A
3/30/2013	4,133	705	N/A	940	N/A
12/31/2012	4,137	721	N/A	902	N/A
9/29/2012	4,166	721	N/A	879	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SN.'s forecast earnings growth (26.4% per year) is above the savings rate (1.4%).

Earnings vs Market: SN.'s earnings (26.4% per year) are forecast to grow faster than the UK market (10.2% per year).

High Growth Earnings: SN.'s earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: SN.'s revenue (5.1% per year) is forecast to grow faster than the UK market (4.1% per year).

High Growth Revenue: SN.'s revenue (5.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: SN.'s Return on Equity is forecast to be low in 3 years time (15.1%).

Discover growth companies

High growth companies in the Healthcare industry.

Smith & Nephew Forecasted Growth

Future criteria checks 4/6

Key information

Recent future growth updates

Smith & Nephew plc Increases Revenue Guidance for 2023

Consensus EPS estimates increase by 10%

Consensus EPS estimates fall by 12%, revenue upgraded

Smith & Nephew plc Announces Revenue Guidance for 2022

Consensus EPS estimates fall by 17%

Smith & Nephew plc Provides Revenue Guidance for the Second Half and Full Year of 2022

Recent updates

Smith & Nephew plc Announces Board and Committee Changes

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 65% Above Its Share Price

Smith & Nephew (LON:SN.) Has A Pretty Healthy Balance Sheet

Smith & Nephew plc Increases Revenue Guidance for 2023

First half 2023 earnings released: EPS: US$0.20 (vs US$0.20 in 1H 2022)

Smith & Nephew plc Announces Step Down of Anne-Françoise Nesmes as Chief Financial Officer

Consensus EPS estimates increase by 10%

Investors Could Be Concerned With Smith & Nephew's (LON:SN.) Returns On Capital

Smith+Nephew Announces 510(K) Clearance of its AETOS Shoulder System

Smith & Nephew plc (LON:SN.) Shares Could Be 22% Below Their Intrinsic Value Estimate

Now 22% undervalued

Smith & Nephew (LON:SN.) Seems To Use Debt Quite Sensibly

Now 20% undervalued

Insider recently bought UK£117k worth of stock

Smith & Nephew (LON:SN.) Will Want To Turn Around Its Return Trends

Upcoming dividend of US$0.23 per share at 2.6% yield

Chief Human Resources Officer recently sold UK£111k worth of stock

Consensus EPS estimates fall by 12%, revenue upgraded

Full year 2022 earnings: EPS misses analyst expectations

Smith & Nephew plc, Annual General Meeting, Apr 26, 2023

Calculating The Intrinsic Value Of Smith & Nephew plc (LON:SN.)

We Think Smith & Nephew (LON:SN.) Can Stay On Top Of Its Debt

High number of new directors

CEO & Director exercised options to buy UK£59k worth of stock.

Returns On Capital Signal Tricky Times Ahead For Smith & Nephew (LON:SN.)

Smith & Nephew plc to Report Fiscal Year 2022 Results on Feb 21, 2023

Smith & Nephew plc Announces Revenue Guidance for 2022

Smith+Nephew Expands Procedural Innovation with Introduction of JOURNEY(TM) II ROX(TM) Total Knee Solution

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 99% Above Its Share Price

Smith+Nephew First to Market with Revision Knee Indication on Robotics Platform

Upcoming dividend of US$0.14 per share

Smith+Nephew Launches OR3O ™ Dual Mobility System in Japan for Use in Primary and Revision Hip Arthroplasty

Smith+Nephew Announces New Data Furthering a Number of Published Studies Supporting the Use of Its REGENETEN Bioinductive Implant in Rotator Cuff Repair

Smith & Nephew plc to Report Q2, 2023 Results on Aug 03, 2023

Smith & Nephew plc Announces Executive Changes

Chairman recently bought UK£59k worth of stock

These 4 Measures Indicate That Smith & Nephew (LON:SN.) Is Using Debt Reasonably Well

Consensus EPS estimates fall by 17%

First half 2022 earnings released

Smith & Nephew plc Provides Revenue Guidance for the Second Half and Full Year of 2022

There Are Reasons To Feel Uneasy About Smith & Nephew's (LON:SN.) Returns On Capital

Smith+Nephew Launches Clinical Support App to Help Reduce Practice Variation in Wound Care

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 58% Above Its Share Price

Smith & Nephew plc Announces Executive Changes

Smith & Nephew plc Announces Executive Changes

Smith+Nephew Announces First Total Hip Replacement Cases on its CORI Surgical System Using RI.HIP Modeler and RI.HIP Navigation

CEO & Director exercised options and sold UK£897k worth of stock

CEO & Director exercised options and sold UK£339k worth of stock

Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital

High number of new directors

Smith+Nephew Announces New Study Showing GRAFIX™ Membrane Cut the Rate of Diabetic Foot Ulcer Recurrence in Half Compared to Leading Competitors

These 4 Measures Indicate That Smith & Nephew (LON:SN.) Is Using Debt Safely

Upcoming dividend of US$0.23 per share

Independent Non-Executive Director recently bought UK£59k worth of stock

Consensus EPS estimates fall by 20%

Earnings Beat: Smith & Nephew plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Full year 2021 earnings: EPS exceeds analyst expectations

Smith & Nephew plc, Annual General Meeting, Apr 13, 2022

Smith & Nephew plc Provides Revenue Guidance for the Second Half and Year of 2022

Smith+Nephew Expands Next-Generation Handheld Robotic-Assisted CORI™ Surgical System into Total Hip Arthroplasty with RI.HIP NAVIGATION

Smith+Nephew Announces New Indications for Use for its PICO 7 and PICO 14 Single Use Negative Pressure Wound Therapy Systems

Smith & Nephew's (LON:SN.) Returns On Capital Not Reflecting Well On The Business

Smith & Nephew plc (LSE:SN.) acquired Engage Surgical.

Smith & Nephew plc (LSE:SN.) announces an Equity Buyback for $300 million worth of its shares.

Are Investors Undervaluing Smith & Nephew plc (LON:SN.) By 30%?

Smith+Nephew Launches Real Intelligence and CORI Surgical System and Next Generation Handheld Robotics Platform in Canada

Smith+Nephew Launches CORI Handheld Robotics

Insider recently sold UK£160k worth of stock

Smith & Nephew (LON:SN.) Might Be Having Difficulty Using Its Capital Effectively